Ask the Expert: Interim PET-CT in Evaluation Lymphoma Treatment Response

2012 Jan 30, Andre Goy, MD

"Ask the Expert” features answers by our experts to your clinical questions. Question: What is the role of PET-CT in evaluating the interim response of lymphoma to treatment?Answer: That’s an interesting question. There have been relevant data presented at the last two or three ASCO and ASH meetings on this topic.The study of interim PET scan is inherently controversial because of issues related to reproducibility, false-positives, grey-zone SUV values, and lack of good harmonization criteria, in...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Seminal Articles

The definitive list of must-read articles for practicing oncologists

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration